HNI Stock Analysis: HNI | NYSE
Furnishings, Fixtures & Appliances | NYSE, USA | Market Cap: 3.527m USD | 12M Return: 13.3% | US4042511000 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 25.2M
EPS Trend: 89.1%
Qual. Beats: 1
Rev. Trend: 77.6%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
HNI Corporation is a U.S.-based manufacturer operating two business segments: Workplace Furnishings and Residential Building Products. The Workplace Furnishings segment produces a broad range of office and commercial furniture - including panel systems, seating, tables, storage, architectural products, and hospitality lines - distributed through independent and company-owned dealers, office product distributors, and direct sales to corporations and government entities. The Residential Building Products segment manufactures gas, wood, electric, and pellet-fueled fireplaces, inserts, stoves, facings, and outdoor hearth products, sold through a national network of independent dealers and distributors as well as company-owned retail and installation outlets. The company markets products under a large portfolio of brands, including HON, Kimball, Allsteel, Gunlocke, HBF, and National, and is headquartered in Muscatine, Iowa, having been incorporated in 1944.
The workplace furnishings industry is closely tied to corporate real estate spending, office occupancy rates, and broader business investment cycles, while the residential hearth business is driven by housing starts, remodeling activity, and consumer discretionary spending. HNIs combined business model spans both the commercial and consumer sides of the home and office environment, with most revenue generated in the United States and Canada.
- Workplace furnishings demand weakens as return-to-office stalls
- Residential fireplace sales pressured by cooling housing market
- Input cost inflation and pricing competition squeeze operating margins
| Net Income: 4.30m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.02 > 0.02 and ΔFCF/TA -11.02 > 1.0 |
| NWC/Revenue: 8.54% < 20% (prev 7.24%; Δ 1.30% < -1%) |
| CFO/TA 0.01 > 3% & CFO 28.8m > Net Income 4.30m |
| Net Debt (1.84b) to EBITDA (331.8m): 5.54 < 3 |
| Current Ratio: 1.36 > 1.5 & < 3 |
| Outstanding Shares: last quarter (72.1m) vs 12m ago 53.08% < -2% |
| Gross Margin: 40.01% > 18% (prev 40.22%; Δ -0.21% > 0.5%) |
| Asset Turnover: 130.5% > 50% (prev 135.0%; Δ -4.49% > 0%) |
| Interest Coverage Ratio: 2.0 > 6 (EBIT TTM 133.8m / Interest Expense TTM 66.9m) |
| A: 0.08 (Total Current Assets 1.41b - Total Current Liabilities 1.04b) / Total Assets 4.82b |
| B: 0.11 (Retained Earnings 551.4m / Total Assets 4.82b) |
| C: 0.04 (EBIT TTM 133.8m / Avg Total Assets 3.36b) |
| D: 0.60 (Book Value of Equity 1.81b / Total Liabilities 3.01b) |
| Altman-Z'' = 1.78 = BBB |
| DSRI: 1.26 (Receivables 629.4m/293.6m, Revenue 4.39b/2.58b) |
| GMI: 1.01 (GM 40.22% / 40.01%) |
| AQI: 1.25 (AQ_t 0.44 / AQ_t-1 0.35) |
| SGI: 1.70 (Revenue 4.39b / 2.58b) |
| TATA: -0.01 (NI 4.30m - CFO 28.8m) / TA 4.82b) |
| Beneish M = -2.15 (Cap -4..+1) = BB |
As of August 20, 2026, the stock is trading at USD 48.39 with a total of 337,895 shares traded. Over the past week, the price has changed by -1.73%, over one month by +17.20%, over three months by +67.28% and over the past year by +13.33%.
Current recommended Stop Loss: 46.10 (which is 4.7% or 1.4 ATR below the current price).
HNI has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy HNI.
- StrongBuy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 69.8 | 44.1% |
P/E Forward = 12.2699
P/S = 0.803
P/B = 1.9537
P/EG = 0.6138
Revenue TTM = 4.39b USD
EBIT TTM = 133.8m USD
EBITDA TTM = 331.8m USD
Long Term Debt = 1.36b USD (from longTermDebt, last quarter)
Short Term Debt = 120.6m USD (from shortTermDebt, last quarter)
Debt = 1.95b USD (from shortLongTermDebtTotal, last quarter) + Leases 268.9m
Net Debt = 1.84b USD (calculated: Debt 1.95b - CCE 108.2m)
Enterprise Value = 5.36b USD (3.53b + Debt 1.95b - CCE 108.2m)
Interest Coverage Ratio = 2.0 (Ebit TTM 133.8m / Interest Expense TTM 66.9m)
EV/FCF = -52.03x (Enterprise Value 5.36b / FCF TTM -103.1m)
FCF Yield = -1.92% (FCF TTM -103.1m / Enterprise Value 5.36b)
FCF Margin = -2.35% (FCF TTM -103.1m / Revenue TTM 4.39b)
Net Margin = 0.10% (Net Income TTM 4.30m / Revenue TTM 4.39b)
Gross Margin = 40.01% ((Revenue TTM 4.39b - Cost of Revenue TTM 2.63b) / Revenue TTM)
Gross Margin QoQ = 43.96% (prev 34.60%)
Tobins Q-Ratio = 1.11 (Enterprise Value 5.36b / Total Assets 4.82b)
Interest Expense / Debt = 3.44% (Interest Expense 66.9m / Debt 1.95b)
Taxrate = 28.23% (20.1m / 71.2m)
NOPAT = 96.0m (EBIT 133.8m * (1 - 28.23%))
Current Ratio = 1.36 (Total Current Assets 1.41b / Total Current Liabilities 1.04b)
Debt / Equity = 1.08 (Debt 1.95b / totalStockholderEquity, last quarter 1.81b)
Debt / EBITDA = 5.54 (Net Debt 1.84b / EBITDA 331.8m)
Debt / FCF = -17.82 (negative FCF - burning cash) (Net Debt 1.84b / FCF TTM -103.1m)
Total Stockholder Equity = 1.56b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.13% (Net Income 4.30m / Total Assets 4.82b)
RoE = 0.28% (Net Income TTM 4.30m / Total Stockholder Equity 1.56b)
RoCE = 4.58% (EBIT 133.8m / Capital Employed (Equity 1.56b + L.T.Debt 1.36b))
RoIC = 2.53% (NOPAT 96.0m / Invested Capital 3.79b)
WACC = 6.85% (E(3.53b)/V(5.47b) * Re(9.27%) + D(1.95b)/V(5.47b) * Rd(3.44%) * (1-Tc(0.28)))
Discount Rate = 9.27% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 66.38 | Cagr: 19.71%
[DCF] Fair Price = unknown (Cash Flow -103.1m)
EPS Correlation: 89.11 | EPS CAGR: 14.75% | SUE: 2.31 | # QB: 1
Revenue Correlation: 77.57 | Revenue CAGR: 17.08% | SUE: -0.06 | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.40 | Chg30d=+6.76% | Revisions=+50% | Analysts=4
EPS current Year (2026-12-31): EPS=4.25 | Chg30d=+5.50% | Revisions=+50% | GrowthEPS=+23.0% | GrowthRev=+110.8%
EPS next Year (2027-12-31): EPS=4.83 | Chg30d=+0.00% | Revisions=+0% | GrowthEPS=+13.6% | GrowthRev=+3.7%
[Analyst] Revisions Ratio: +55% (up=7, down=1)